Resultados de la búsqueda 901-910 of 19441 for WHO
... who receive anti-HER2 therapies, such as trastuzumab, pertuzumab, lapatinib ... The primary purpose of this study is to collect Biospecimens from patients who ...
... who are refractory to or intolerant to other available therapies. Also, to ... who have not received doxorubicin or checkpoint inhibitors and are ...
The primary objective of the United States Food and Drug Administration (FDA) for this study is to demonstrate non-inferiority in subjects who received an ...
The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been ...
Consultar al dentista con regularidad es una parte importante de la salud bucodental. También lo es cuidar los dientes y las encías para que se mantengan sanos.
... who have rhabdomyosarcoma with DNA mutations get separate treatment. Finally, this study examines the effect of therapy intensification in patients who have ...
The purpose of this study is to look at the blood's clotting response in people who have suffered a traumatic injury and compare it with non-injured people.
... Who is at risk? Aug. 22, 2024, 02:59 p.m. CDT · Mayo Clinic Minute: 4 ideas ... Mayo Clinic Minute: Who should be screened for skin cancer? May 15, 2024 ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?